Dangerous Drugs and Defective Medical Devices
If you've been hurt by a dangerous product, we're on your side
Consumers have a right to expect that any product they use is safe and effective, and that goes double for drugs and devices used to treat medical conditions. Pharmaceutical companies and medical equipment manufacturers have a responsibility to test their products thoroughly and disclose all potential risks of injury to both patients and medical professionals.
Some defective drugs and medical devices just don’t work. They may not cause any direct harm, but they leave users with untreated medical conditions, which can lead to serious future complications. Other products are simply dangerous – a medication may have serious side effects or a medical device may break apart and cause organ damage. In either case, these dangerous products can cause serious injury and death.
New medicines and medical devices are hitting the market every day. That's why it's impossible to create an exhaustive list. If you've been hurt by any medical product, you need an experienced, passionate personal injury attorney on your side. You need Dean Waite.
You have rights as an injured patient. Don't hesitate. Call Dean Waite
Liability claims involving dangerous drugs and defective medical devices fall under the legal category of product liability. In order to recover financial compensation, we'll help you prove that the company responsible for the medical product was negligent according to one or more of the following criteria:
- Design defects or shoddy manufacturing
- Inadequate testing before seeking FDA approval
- Failure to warn of dangers associated with the medication
- Making false claims or misrepresenting information
- Failure to monitor or follow up on claims of injury or adverse side effects
Taking on a major pharmaceutical company or drug distributor is no small task. Such multi-national companies often have teams of well-paid attorneys who know how to fight such claims. At Dean Waite & Associates, LLC, we're not afraid to stand up to big corporations. We have the resources, experience and knowledge of the legal system needed to build your case and get results.
This year, the DePuy Synthes Attune Knee Replacement System has been linked to significant injury risks that can severely and adversely impact quality of life for patients.
The most common mechanism of injury is loosening of the tibial plate, as well as loss or lack of bonding between the implant’s knee component and the tibial bone. This loosening can cause the knee replacement device to fail within one to two years of surgery, but often fails within mere months.
This instability and loosening can lead to several serious side effects, including:
- Persistent pain
- Loss of range of motion
Patients who have sustained these side effects likely need to undergo revision surgery to replace the implant. These surgeries are generally more invasive and painful than the initial knee replacement, leading to significant costs and losses for the patient.
Dean Waite & Associates, LLC is currently reviewing cases involving defective DePuy knee replacements. If you or a loved one is experiencing side effects or has had to undergo revision surgery following a knee replacement, we want to hear from you today. You may be entitled to significant compensation.
Invokana, also known generically as canagliflozin, is a medication prescribed to treat Type 2 diabetes. The first in a family of antidiabetic medications called SGLT2 medications, Invokana is manufactured and marketed in the United States by Janssen Pharmaceuticals, which is a subsidiary of Johnson & Johnson.
Lawsuits involving Invokana center on a serious medical risk associated with the drug: diabetic ketoacidosis (DKA), a potentially deadly medical condition that creates high levels of ketones in the bloodstream and causes the blood to become acidic. Symptoms of DKA include:
- Increased thirst
- Increased urination
- Abdominal pain
- Fatigue and weakness
- Shortness of breath
- "Fruity" breath
- Dizziness or fainting
- Trouble breathing
Ketoacidosis can become life-threatening extremely quickly and warrants immediate medical attention. And because DKA is a rare condition in general, many may not recognize the symptoms until it is too late.
The original prescribing information for Invokana did not warn patients or prescribers that DKA was a side effect or risk of taking the medication, and lawsuits allege that Janssen did not do enough to warn patients of the risks associated with this dangerous drug. If you or a loved one developed DKA after taking Invokana, you need to talk to an attorney today.
Xarelto, one of the newest blood thinners available to patients, has been marketed by manufacturer Janssen Pharmaceutical as a safe and effective alternative to other blood thinners such as warfarin. However, several recent cases have linked Xarelto to dangerous and potentially fatal complications.
Like any anticoagulant, Xarelto can cause bleeding complications; after all, the very purpose of the drug is to prevent blood from clotting. However, unlike other blood thinners, Xarelto has no antidote, which means there is no effective way for doctors to stop a Xarelto patient from bleeding in the event of an emergency. Other anticoagulants can be effectively countered with high dosages of Vitamin K.
A patient taking Xarelto who suffers an internal injury is vulnerable to extreme or fatal blood loss due to internal bleeding. Other potential injuries associated with Xarelto include infection, decreased hemoglobin, bleeding in the brain, dyspnea (difficulty breathing) and peripheral edema (swelling of the lower limbs).
Because Xarelto is still a relatively new drug, investigations regarding its legal implications are still in their early stages. However, there is strong reason to believe that Janssen failed to disclose information about the drug's dangers and aggressively marketed their product as a safe and effective alternative despite being aware of the risk of serious complications. If you've taken Xarelto and suffered injury as a result, call Dean Waite & Associates today.